We hope you'll be joining us at the #BAARN2023 poster session this Friday, where our #DZD team will be presenting our #sequencing-based #diagnostic technology and workflows 🤓🧬🩸msi.harvard.edu/baarn

Kate, Anna, and Jenna from #DZD will also present our Blood2Bac proprietary technology at the #BAARN2023 poster session this Friday; stop by to learn more! 🤓🧬🩸 msi.harvard.edu/baarn

See you tomorrow at BAARN! Don't miss our CEO's talk during the Advances in Diagnostics Session at 11 am, and be sure to stop by our two posters at the 5 pm Poster Session! (P.S. Registration closes at 3 pm today) #AMR

We had a great time at #BAARN2023! Thanks for attending our talk and stopping by our posters. If you have any follow-up questions, DM us, and we can always set up a meeting. 🧬🧪🧫 Looking forward to next year! #AMR Harvard Microbial Sciences Initiative (MSI)

It's been a wild couple of weeks as we've transitioned to the new #DZD HQ at 250 Arsenal. Dangerously popping bottles of champagne with our CSO's sword is the only way we know how to celebrate. 😉Cheers to #NewBeginnings #TheDZDWay #Growth #DreamTeam 🥳🎉🍾(more photos to come!)

According to World Health Organization (WHO), #AMR could result in $1 trillion additional healthcare costs worldwide by 2050 and between $1 trillion and $3.4 trillion gross domestic product (GDP) losses per year by 2030: buff.ly/33Zl6nU

Emergence of unusual resistance patterns across different bacterial strains and species might call for the challenging detection of #plasmids as a transmission source. Find out why, and how #ONT Long-read #WGS can help in our latest blog article. #AMR#HAI dayzerolab.com/2023/12/21/pla…

An exciting year-end at #DZD with our product engineering team celebrating a significant milestone to close it out! #HappyHolidays to you and your loved ones!🍾🧪🧬🎉❄️

Happy New Year from #DZD! We've set some significant goals for 2024 and are excited to get to work. 🎉🧪🦾 Enjoy your year, and this dad joke: "Why don't #bacteria need New Year's resolutions? Because they're already so good at multiplying their successes!" #Sepsis #AMR #WGS

The global health community faces a daunting challenge: the rise of #superbugs in war zones. This article highlights the urgency of developing rapid #diagnostic tools and new treatments for bacterial, fungal, and viral pathogens. 🧪🔬 #AMR #DZD #WGS harvardpublichealth.org/conflict-healt…

"...When testing is based solely on cultures, there is no opportunity to adjust a patient’s treatment... Not only does it lead to poorer patient outcomes, but it also contributes to the growing epidemic of antibiotic resistance." ow.ly/1ttK50QtH7k? #Genomics #WGS #AMR

It's scary how a small finger cut can turn into a life-threatening situation in a few days. Our engineer Nick brought his dad in last week to share his unbelievable story with us. It was a powerful moment that reminded us of what we are grinding day in and day out for. #Sepsis

Analysis of both patient and environmental samples is often essential when it comes to #bacterial & #fungal outbreak investigations. This interview from Infection Control Today explains why... #WGS #HAI #CDiff #InfectionControl ow.ly/ZivE50QxWKk

Great #GroundTrouths article by Eric Topol ! We agree... there's no way to avoid integration of #AI into #Diagnostics. These two will go hand and hand in improving the accuracy and validity of tools our medical systems are coming to rely on. #ML ow.ly/UOPc50QyRNy

📣 PUBLISHED TODAY: CARB-X’s 2023 Annual Report is out! The report highlights key takeaways from the portfolio strategy review, funding round results, our work in low- and middle-income countries, new CARB-X funders, & more: bit.ly/49YZjOx

Attending ASM Microbe 2024 in Atlanta? Come check-out Jason Wittenbach’s talk on Friday, June 14. Jason will talk about Direct-from-Blood Predictive AST from Clinical Samples at the Rapid AST and Diagnostic Methods session. #DZD #WGS #rapiddiagnostics #antimicrobialresistance

Are you planning to attend ASM Microbe this year? Jason Wittenbach will be presenting #DZD’s Large-Scale Predictive AST using #MachineLearning and #WGS study on Saturday, June 15. Come check it out. #rapiddiagnostics #antimicrobialresistance

If you happen to be around at ASM Microbe on Saturday, June 15, we invite you to visit our poster: Rapid Species ID and AST Direct from Whole Blood: Initial Results from a Feasibility Study in Patients with Suspected Blood Stream Infection presented by Nicole Billings. #sepsis

Honored to be featured in a press release by #ASMMicrobe. Great presentation by Jason Wittenbach. AI Enables Faster, More Effective Antibiotic Treatment of Sepsis | ASM.org

We had an exceptional conference at ASM Microbe 2024, where we presented 3 studies focusing on rapid AST using machine learning. Kudos to the #DZD team Jason Wittenbach and Nicole Billings for outstanding presentations. prnewswire.com/news-releases/…